126 related articles for article (PubMed ID: 18058365)
1. alpha6 integrin cleavage: sensitizing human prostate cancer to ionizing radiation.
Pawar SC; Dougherty S; Pennington ME; Demetriou MC; Stea BD; Dorr RT; Cress AE
Int J Radiat Biol; 2007; 83(11-12):761-7. PubMed ID: 18058365
[TBL] [Abstract][Full Text] [Related]
2. Integrin alpha6 cleavage: a novel modification to modulate cell migration.
Pawar SC; Demetriou MC; Nagle RB; Bowden GT; Cress AE
Exp Cell Res; 2007 Apr; 313(6):1080-9. PubMed ID: 17303120
[TBL] [Abstract][Full Text] [Related]
3. The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model.
King TE; Pawar SC; Majuta L; Sroka IC; Wynn D; Demetriou MC; Nagle RB; Porreca F; Cress AE
PLoS One; 2008; 3(10):e3535. PubMed ID: 18958175
[TBL] [Abstract][Full Text] [Related]
4. Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.
Rubenstein CS; Gard JMC; Wang M; McGrath JE; Ingabire N; Hinton JP; Marr KD; Simpson SJ; Nagle RB; Miranti CK; Warfel NA; Garcia JGN; Arif-Tiwari H; Cress AE
Cancer Res; 2019 Sep; 79(18):4703-4714. PubMed ID: 31337652
[TBL] [Abstract][Full Text] [Related]
5. Extracellular engagement of alpha6 integrin inhibited urokinase-type plasminogen activator-mediated cleavage and delayed human prostate bone metastasis.
Ports MO; Nagle RB; Pond GD; Cress AE
Cancer Res; 2009 Jun; 69(12):5007-14. PubMed ID: 19491258
[TBL] [Abstract][Full Text] [Related]
6. Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Hoogland AM; Verhoef EI; Roobol MJ; Schröder FH; Wildhagen MF; van der Kwast TH; Jenster G; van Leenders GJ
Prostate; 2014 May; 74(5):488-96. PubMed ID: 24375374
[TBL] [Abstract][Full Text] [Related]
7. Identification of the cleavage sites in the alpha6A integrin subunit: structural requirements for cleavage and functional analysis of the uncleaved alpha6Abeta1 integrin.
Delwel GO; Kuikman I; van der Schors RC; de Melker AA; Sonnenberg A
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):263-72. PubMed ID: 9164866
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.
Das L; Anderson TA; Gard JM; Sroka IC; Strautman SR; Nagle RB; Morrissey C; Knudsen BS; Cress AE
J Cell Biochem; 2017 May; 118(5):1038-1049. PubMed ID: 27509031
[TBL] [Abstract][Full Text] [Related]
9. Functional p53 increases prostate cancer cell survival after exposure to fractionated doses of ionizing radiation.
Scott SL; Earle JD; Gumerlock PH
Cancer Res; 2003 Nov; 63(21):7190-6. PubMed ID: 14612513
[TBL] [Abstract][Full Text] [Related]
10. Integrin α6(high) cell population functions as an initiator in tumorigenesis and relapse of human liposarcoma.
Wang L; Wang L; Gu Y; Shu Y; Shen Y; Xu Q
Mol Cancer Ther; 2011 Dec; 10(12):2276-86. PubMed ID: 21980129
[TBL] [Abstract][Full Text] [Related]
11. Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.
Kacsinta AD; Rubenstein CS; Sroka IC; Pawar S; Gard JM; Nagle RB; Cress AE
Biochem Biophys Res Commun; 2014 Nov; 454(2):335-40. PubMed ID: 25450398
[TBL] [Abstract][Full Text] [Related]
12. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex.
Lee SH; Hatakeyama S; Yu SY; Bao X; Ohyama C; Khoo KH; Fukuda MN; Fukuda M
J Biol Chem; 2009 Jun; 284(25):17157-17169. PubMed ID: 19395705
[TBL] [Abstract][Full Text] [Related]
13. Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo.
Marr KD; Gard JMC; Harryman WL; Keeswood EJ; Paxson AI; Wolgemuth C; Knudsen BS; Nagle RB; Hazlehurst L; Sorbellini M; Cress AE
Biophys J; 2023 Nov; 122(21):4194-4206. PubMed ID: 37766428
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha6 subunit expression.
Yamamoto H; Irie A; Fukushima Y; Ohnishi T; Arita N; Hayakawa T; Sekiguchi K
Int J Cancer; 1996 Feb; 65(4):519-24. PubMed ID: 8621237
[TBL] [Abstract][Full Text] [Related]
15. Site-specific S-nitrosylation of integrin α6 increases the extent of prostate cancer cell migration by enhancing integrin β1 association and weakening adherence to laminin-1.
Isaac J; Tarapore P; Zhang X; Lam YW; Ho SM
Biochemistry; 2012 Dec; 51(48):9689-97. PubMed ID: 23106339
[TBL] [Abstract][Full Text] [Related]
16. β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.
Goel HL; Sayeed A; Breen M; Zarif MJ; Garlick DS; Leav I; Davis RJ; Fitzgerald TJ; Morrione A; Hsieh CC; Liu Q; Dicker AP; Altieri DC; Languino LR
J Cell Physiol; 2013 Jul; 228(7):1601-9. PubMed ID: 23359252
[TBL] [Abstract][Full Text] [Related]
17. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer.
Demetriou MC; Pennington ME; Nagle RB; Cress AE
Exp Cell Res; 2004 Apr; 294(2):550-8. PubMed ID: 15023541
[TBL] [Abstract][Full Text] [Related]
18. Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.
Landowski TH; Gard J; Pond E; Pond GD; Nagle RB; Geffre CP; Cress AE
Mol Cancer Ther; 2014 Jun; 13(6):1558-66. PubMed ID: 24739392
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion.
He B; Liu L; Cook GA; Grgurevich S; Jennings LK; Zhang XA
J Biol Chem; 2005 Feb; 280(5):3346-54. PubMed ID: 15557282
[TBL] [Abstract][Full Text] [Related]
20. UNC5C‑knockdown enhances the growth and metastasis of breast cancer cells by potentiating the integrin α6/β4 signaling pathway.
Yuan M; Xie F; Xia X; Zhong K; Lian L; Zhang S; Yuan L; Ye J
Int J Oncol; 2020 Jan; 56(1):139-150. PubMed ID: 31789389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
